• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Piriformis Syndrome Market Trends

    ID: MRFR/Pharma/4788-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Piriformis Syndrome Market Research Report Information By Cause (Trauma, Spasms, Others), Diagnostic Test (MRI, Others), Treatment (Medication, Physical Therapy, Others), Distribution Channel (Retail Pharmacies, Others), End-User – Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Piriformis Syndrome Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Trends

    Key Emerging Trends in the Piriformis Syndrome Market

    One critical pattern is the raising occurrence of Piriformis Syndrome. The condition, described by the pressure of the sciatic nerve by the piriformis muscle, has seen an observable increase in revealed cases. This ascent is ascribed to increased awareness among medical care experts and worked on indicative capacities. The market is seeing a surge in demonstrative progressions for Piriformis Syndrome. Developments like high level imaging methods, including attractive reverberation imaging (X-ray) and ultrasound, have worked on the precision of conclusion, empowering medical care suppliers to really distinguish and treat the condition more. The syndrome's frequency is strikingly high among participants, attributable to the tedious pressure put on the piriformis muscle during specific exercises. Furthermore, a stationary way of life has added to an expansion in revealed cases, as delayed sitting can prompt muscle stiffness and pressure of the sciatic nerve. There is a developing pattern towards harmless treatment choices for Piriformis Syndrome. Physical therapy, extending activities, and lifestyle alterations are acquiring noticeable quality as essential mediations. This shift mirrors a longing to limit the requirement for surgeries and diminish the in general financial weight on patients and medical care frameworks. The market is encountering expanded innovative work exercises pointed toward investigating novel treatment modalities for Piriformis Syndrome. Drug organizations and clinical gadget producers are putting resources into the advancement of designated medications and remedial gadgets to address the necessities of people impacted by the condition. Innovation is assuming a critical part in molding the market patterns. Portable applications and wearable gadgets intended to help with locally situated activities and observing of side effects are acquiring fame. This reconciliation of innovation improves patient commitment as well as gives important information to medical care experts to follow and recreate therapy plans.

    Market Summary

    The global Piriformis Syndrome market is projected to grow from 171.9 USD Million in 2024 to 330.0 USD Million by 2035.

    Key Market Trends & Highlights

    Piriformis Syndrome Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate of 6.11 percent from 2025 to 2035. By 2035, the market valuation is anticipated to reach 330.0 USD Million, indicating robust growth. In 2024, the market is valued at 171.9 USD Million, reflecting the increasing awareness and diagnosis of Piriformis Syndrome. Growing adoption of advanced therapeutic techniques due to rising prevalence of musculoskeletal disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 171.9 (USD Million)
    2035 Market Size 330.0 (USD Million)
    CAGR (2025-2035) 6.11%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Bayer AG, Novartis AG, AstraZeneca, Endo Pharmaceuticals, Teva Pharmaceuticals, Omron Healthcare, Sanofi S.A., DePuy Synthes Companies, Miracle Stretch, LLC, Flex Pharma, Inc., Nidd valley medical, SEIRIN Corporation, Others</p>

    Market Trends

    <p>The increasing prevalence of musculoskeletal disorders, including Piriformis Syndrome, underscores the necessity for enhanced diagnostic and therapeutic approaches in the healthcare sector.</p>

    Centers for Disease Control and Prevention (CDC)

    Piriformis Syndrome Market Market Drivers

    Market Growth Projections

    The Global Piriformis Syndrome Market Industry is projected to experience substantial growth over the next decade. With an estimated market value of 171.9 USD Million in 2024, the industry is expected to reach 330.0 USD Million by 2035. This growth trajectory suggests a compound annual growth rate of 6.11% from 2025 to 2035. Such projections indicate a robust demand for effective treatment options and highlight the increasing recognition of Piriformis Syndrome as a significant health concern. The market's expansion reflects the ongoing efforts to improve patient care and enhance treatment modalities.

    Increased Awareness and Diagnosis

    The growing awareness of Piriformis Syndrome among healthcare professionals and the general public is a significant driver for the Global Piriformis Syndrome Market Industry. Enhanced education and training for clinicians lead to more accurate diagnoses, which in turn encourages patients to seek treatment. Public health campaigns and resources available online contribute to this awareness, helping individuals recognize symptoms earlier. As a result, the market is likely to see an increase in demand for diagnostic tools and therapeutic interventions. This heightened awareness is expected to support the market's growth trajectory, with projections indicating a rise to 330.0 USD Million by 2035.

    Integration of Telehealth Services

    The integration of telehealth services into the management of Piriformis Syndrome is transforming the Global Piriformis Syndrome Market Industry. Telehealth offers patients convenient access to healthcare professionals, particularly for those in remote areas or with mobility challenges. This shift not only enhances patient engagement but also facilitates timely diagnosis and treatment. As telehealth continues to gain traction, it is likely to expand the reach of healthcare providers and improve patient outcomes. The ongoing evolution of telehealth services may further stimulate market growth, as more patients utilize these platforms for managing their conditions.

    Advancements in Treatment Modalities

    Innovations in treatment options for Piriformis Syndrome are propelling the Global Piriformis Syndrome Market Industry forward. Recent advancements include minimally invasive surgical techniques, physical therapy, and the use of targeted injections. These developments enhance patient outcomes and reduce recovery times, making treatment more appealing. Furthermore, the introduction of new therapeutic devices and medications is likely to improve the management of this condition. As the market evolves, it is anticipated that the Global Piriformis Syndrome Market will experience a compound annual growth rate of 6.11% from 2025 to 2035, driven by these advancements.

    Rising Prevalence of Piriformis Syndrome

    The increasing incidence of Piriformis Syndrome is a notable driver for the Global Piriformis Syndrome Market Industry. Factors such as sedentary lifestyles and the growing aging population contribute to this trend. Reports indicate that the prevalence of this condition is rising, particularly among individuals engaged in repetitive activities or prolonged sitting. As awareness of this syndrome grows, more patients seek medical intervention, thereby expanding the market. The Global Piriformis Syndrome Market is projected to reach 171.9 USD Million by 2024, reflecting the urgent need for effective treatment options and management strategies.

    Growing Demand for Rehabilitation Services

    The increasing demand for rehabilitation services for individuals suffering from Piriformis Syndrome is a crucial driver for the Global Piriformis Syndrome Market Industry. Rehabilitation programs focusing on physical therapy, exercise regimens, and pain management are becoming more prevalent. This trend is largely influenced by the rising number of patients seeking non-invasive treatment options. As healthcare systems prioritize rehabilitation to improve quality of life, the market is expected to expand significantly. The emphasis on holistic approaches to treatment aligns with the growing preference for personalized care, further supporting the market's development.

    Market Segment Insights

    Regional Insights

    Key Companies in the Piriformis Syndrome Market market include

    Industry Developments

    Future Outlook

    Piriformis Syndrome Market Future Outlook

    <p>The Global Piriformis Syndrome Market is projected to grow at a 6.11% CAGR from 2024 to 2035, driven by increasing awareness, innovative treatment options, and rising healthcare expenditures.</p>

    New opportunities lie in:

    • <p>Develop targeted therapies leveraging advanced biotechnology for personalized treatment. Expand telehealth services to enhance patient access and management of Piriformis Syndrome. Invest in educational programs for healthcare professionals to improve diagnosis and treatment efficacy.</p>

    <p>By 2035, the market is expected to demonstrate robust growth, reflecting enhanced treatment modalities and increased patient engagement.</p>

    Market Segmentation

    Intended Audience

    • Academic Institutes and Universities
    • Government Research Institute
    • Diagnostic Laboratories
    • Research and Development (R&D) Companies
    • Pharmaceutical Companies

    Research Methodology

    • Primary Research
    • Secondary Research

    Piriformis Syndrome Market Overview

    • Primary Research
    • Secondary Research

    The Market of Piriformis syndrome, by Cause

    • Others
    • Overuse injury
    • Spasms
    • Trauma
    • Others
    • FAIR (Flexion
    • adduction
    • and Internal Rotation) Test
    • Beatty Test
    • Electromyography (EMG)
    • Neurophysiologic Testing
    • X-rays
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Others
    • Surgery
    • Osteopathic Manipulative Treatment (OMT)
    • Prolotherapy
    • Acupuncture
    • Physical Therapy
    • Others
    • Steroid Injection
    • Botox Injection
    • Piriformis Muscle Injection
    • Others
    • Ibuprofen
    • Naproxen
    • NSAIDS
    • Medication
    • Others
    • Retail Pharmacies
    • E-Commerce
    • Others
    • Diagnostic Centers
    • Hospitals & Clinics
    • Africa
    • Middle East
    • The Middle East & Africa
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Asia-Pacific
    • Eastern Europe
    • Rest of Western Europe
    • UK
    • Spain
    • Italy
    • France
    • Germany
    • Western Europe
    • Europe
    • South America
    • Canada
    • US
    • North America
    • Americas
    • Academic Institutes and Universities
    • Government Research Institute
    • Diagnostic Laboratories
    • Research and Development (R&D) Companies
    • Pharmaceutical Companies

    Piriformis Syndrome Market Regional Analysis

    • Others
    • Overuse injury
    • Spasms
    • Trauma
    • Others
    • FAIR (Flexion
    • adduction
    • and Internal Rotation) Test
    • Beatty Test
    • Electromyography (EMG)
    • Neurophysiologic Testing
    • X-rays
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Others
    • Surgery
    • Osteopathic Manipulative Treatment (OMT)
    • Prolotherapy
    • Acupuncture
    • Physical Therapy
    • Others
    • Steroid Injection
    • Botox Injection
    • Piriformis Muscle Injection
    • Others
    • Ibuprofen
    • Naproxen
    • NSAIDS
    • Medication
    • Others
    • Retail Pharmacies
    • E-Commerce
    • Others
    • Diagnostic Centers
    • Hospitals & Clinics
    • Africa
    • Middle East
    • The Middle East & Africa
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Asia-Pacific
    • Eastern Europe
    • Rest of Western Europe
    • UK
    • Spain
    • Italy
    • France
    • Germany
    • Western Europe
    • Europe
    • South America
    • Canada
    • US
    • North America
    • Americas
    • Academic Institutes and Universities
    • Government Research Institute
    • Diagnostic Laboratories
    • Research and Development (R&D) Companies
    • Pharmaceutical Companies

    The Market of Piriformis syndrome, by Region

    • Africa
    • Middle East
    • The Middle East & Africa
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Asia-Pacific
    • Eastern Europe
    • Rest of Western Europe
    • UK
    • Spain
    • Italy
    • France
    • Germany
    • Western Europe
    • Europe
    • South America
    • Canada
    • US
    • North America
    • Americas
    • Academic Institutes and Universities
    • Government Research Institute
    • Diagnostic Laboratories
    • Research and Development (R&D) Companies
    • Pharmaceutical Companies

    Key Players in the Piriformis Syndrome Market

    • Others
    • SEIRIN Corporation
    • Nidd valley medical
    • Flex Pharma
    • Inc.
    • Miracle Stretch
    • LLC
    • DePuy Synthes Companies
    • Sanofi S.A.
    • Omron Healthcare
    • Teva Pharmaceuticals
    • Endo Pharmaceuticals
    • AstraZeneca
    • Novartis AG
    • Bayer AG

    The Market of Piriformis syndrome, by End-User

    • Others
    • Diagnostic Centers
    • Hospitals & Clinics
    • Africa
    • Middle East
    • The Middle East & Africa
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Asia-Pacific
    • Eastern Europe
    • Rest of Western Europe
    • UK
    • Spain
    • Italy
    • France
    • Germany
    • Western Europe
    • Europe
    • South America
    • Canada
    • US
    • North America
    • Americas
    • Academic Institutes and Universities
    • Government Research Institute
    • Diagnostic Laboratories
    • Research and Development (R&D) Companies
    • Pharmaceutical Companies

    The Market of Piriformis syndrome, by Treatment

    • Others
    • Surgery
    • Osteopathic Manipulative Treatment (OMT)
    • Prolotherapy
    • Acupuncture
    • Physical Therapy
    • Others
    • Steroid Injection
    • Botox Injection
    • Piriformis Muscle Injection
    • Others
    • Ibuprofen
    • Naproxen
    • NSAIDS
    • Medication
    • Others
    • Retail Pharmacies
    • E-Commerce
    • Others
    • Diagnostic Centers
    • Hospitals & Clinics
    • Africa
    • Middle East
    • The Middle East & Africa
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Asia-Pacific
    • Eastern Europe
    • Rest of Western Europe
    • UK
    • Spain
    • Italy
    • France
    • Germany
    • Western Europe
    • Europe
    • South America
    • Canada
    • US
    • North America
    • Americas
    • Academic Institutes and Universities
    • Government Research Institute
    • Diagnostic Laboratories
    • Research and Development (R&D) Companies
    • Pharmaceutical Companies

    The Market of Piriformis syndrome, by Diagnostic Test

    • Others
    • FAIR (Flexion
    • adduction
    • and Internal Rotation) Test
    • Beatty Test
    • Electromyography (EMG)
    • Neurophysiologic Testing
    • X-rays
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Others
    • Surgery
    • Osteopathic Manipulative Treatment (OMT)
    • Prolotherapy
    • Acupuncture
    • Physical Therapy
    • Others
    • Steroid Injection
    • Botox Injection
    • Piriformis Muscle Injection
    • Others
    • Ibuprofen
    • Naproxen
    • NSAIDS
    • Medication
    • Others
    • Retail Pharmacies
    • E-Commerce
    • Others
    • Diagnostic Centers
    • Hospitals & Clinics
    • Africa
    • Middle East
    • The Middle East & Africa
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Asia-Pacific
    • Eastern Europe
    • Rest of Western Europe
    • UK
    • Spain
    • Italy
    • France
    • Germany
    • Western Europe
    • Europe
    • South America
    • Canada
    • US
    • North America
    • Americas
    • Academic Institutes and Universities
    • Government Research Institute
    • Diagnostic Laboratories
    • Research and Development (R&D) Companies
    • Pharmaceutical Companies

    The Market of Piriformis syndrome, by Distribution Channel

    • Others
    • Retail Pharmacies
    • E-Commerce
    • Others
    • Diagnostic Centers
    • Hospitals & Clinics
    • Africa
    • Middle East
    • The Middle East & Africa
    • Rest of Asia-Pacific
    • Republic of Korea
    • Australia
    • India
    • China
    • Japan
    • Asia-Pacific
    • Eastern Europe
    • Rest of Western Europe
    • UK
    • Spain
    • Italy
    • France
    • Germany
    • Western Europe
    • Europe
    • South America
    • Canada
    • US
    • North America
    • Americas
    • Academic Institutes and Universities
    • Government Research Institute
    • Diagnostic Laboratories
    • Research and Development (R&D) Companies
    • Pharmaceutical Companies

    Report Scope

    Report Attribute/MetricDetails
      Market Size  2030: Significant Value
      CAGR  6.10% (2022 - 2030)
      Base Year  2021
      Forecast Period  2022-2030
      Historical Data  2018
      Forecast Units  Value (USD Million)
      Report Coverage  Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered  By Cause, Diagnostic Test, Treatment, Distribution Channel
      Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors  Bayer AG, Novartis AG, AstraZeneca, Endo Pharmaceuticals, Teva Pharmaceuticals, Omron Healthcare, Sanofi S.A., DePuy Synthes Companies, Miracle Stretch, LLC, Flex Pharma, Inc., Nidd valley medical, SEIRIN Corporation
      Key Market Opportunities  Government support towards research and development expenditure, increasing secondary lifestyle & high concentration of major hospitals in developed countries
      Key Market Drivers·  Growing occurrence of piriformis syndrome ·  Increasing screening for neuromuscular conditions ·  Growing geriatric population

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What would be the CAGR of the piriformis syndrome market during the forecast period (2020-2027)?

    The expected CAGR would be 6.10% for piriformis syndrome market.

    What are the major piriformis syndrome market drivers?

    Major piriformis syndrome market drivers are increasing screening, rising safety and success of drug treatments, the occurrences of piriformis syndrome, and the growing geriatric population.

    What are the treatments included in the piriformis syndrome market study?

    The piriformis syndrome market study would include surgery, physical therapy, medication, prolotherapy, acupuncture, Osteopathic Manipulative Treatment (OMT), and others.

    What are the distribution channels included in the piriformis syndrome market study?

    Piriformis syndrome market study includes diagnostic centers, hospitals and clinics, and others.

    What are the distribution channels mentioned in the piriformis syndrome market study?

    The distribution channels are retail pharmacies, E-commerce, and others in piriformis syndrome market study.

    No Data Available

    Piriformis Syndrome Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials